Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Lilla Reiniger, István Csabai, Francesco Favero, Nicolai J Birkbak, Aron C Eklund, Ali Syed, Zoltan Szallasi. NPJ Breast Cancer 2018
Times Cited: 66
Times Cited: 66
Christopher J Lord, Alan Ashworth. Science 2017
Times Cited: 1105
Times Cited: 1105
List of shared articles
Times cited
Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population.
Chia-Hsin Wu, Chia-Shan Hsieh, Yo-Cheng Chang, Chi-Cheng Huang, Hsien-Tang Yeh, Ming-Feng Hou, Yuan-Chiang Chung, Shih-Hsin Tu, King-Jen Chang, Amrita Chattopadhyay,[...]. Commun Biol 2021
Chia-Hsin Wu, Chia-Shan Hsieh, Yo-Cheng Chang, Chi-Cheng Huang, Hsien-Tang Yeh, Ming-Feng Hou, Yuan-Chiang Chung, Shih-Hsin Tu, King-Jen Chang, Amrita Chattopadhyay,[...]. Commun Biol 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Ritika-Mahmuda Ahmed, Milly Denman, Christopher D Steele, Maxime Tarabichi, Errin Roy, Lauren R Davies, Jiten Manji,[...]. Nat Commun 2021
Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Ritika-Mahmuda Ahmed, Milly Denman, Christopher D Steele, Maxime Tarabichi, Errin Roy, Lauren R Davies, Jiten Manji,[...]. Nat Commun 2021
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem. Cancer Treat Rev 2022
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem. Cancer Treat Rev 2022
Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura,[...]. Breast Cancer Res Treat 2020
Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura,[...]. Breast Cancer Res Treat 2020
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger,[...]. NPJ Precis Oncol 2021
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger,[...]. NPJ Precis Oncol 2021
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher,[...]. J Pathol Clin Res 2022
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher,[...]. J Pathol Clin Res 2022
Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response.
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung-Gie Kim, Eun-Hae Cho, Suhwan Chang,[...]. Cancer Res 2022
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung-Gie Kim, Eun-Hae Cho, Suhwan Chang,[...]. Cancer Res 2022
Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence.
Chia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, Chi-Cheng Huang, Amrita Chattopadhyay, Yuan-Chiang Chung, Shih-Hsin Tu, Yung-Hua Li, Tzu-Pin Lu, Liang-Chuan Lai,[...]. Cancers (Basel) 2021
Chia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, Chi-Cheng Huang, Amrita Chattopadhyay, Yuan-Chiang Chung, Shih-Hsin Tu, Yung-Hua Li, Tzu-Pin Lu, Liang-Chuan Lai,[...]. Cancers (Basel) 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations.
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, Li-Xuan Qin, Ping Chi, Mark Dickson, Mrinal Gounder, Ciara Kelly, Mary L Keohan, Benjamin Nacev,[...]. JCO Precis Oncol 2020
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, Li-Xuan Qin, Ping Chi, Mark Dickson, Mrinal Gounder, Ciara Kelly, Mary L Keohan, Benjamin Nacev,[...]. JCO Precis Oncol 2020
Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.
Can Yang, Zijing Zhang, Xuemei Tang, Xinju Zhang, Yuming Chen, Tingting Hu, Huating Zhang, Ming Guan, Xiuming Zhang, Zhiyuan Wu. Hum Cell 2022
Can Yang, Zijing Zhang, Xuemei Tang, Xinju Zhang, Yuming Chen, Tingting Hu, Huating Zhang, Ming Guan, Xiuming Zhang, Zhiyuan Wu. Hum Cell 2022
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022